# A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Study · id `cardio:ct-nct06008197` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06008197](<https://clinicaltrials.gov/study/NCT06008197>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06008197

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5200 participants.

## Technical summary

Registry record NCT06008197. Randomized; quadruple masking; primary purpose treatment. Start 2024-01-17 (actual); primary completion 2027-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 5200 participants (planned count; ClinicalTrials.gov record NCT06008197, source copy `cardio:ctgov-nct06008197-2026-09-10`, retrieved 2026-10-26)
- Started: 2024-01-17 (actual) (ClinicalTrials.gov record NCT06008197, source copy `cardio:ctgov-nct06008197-2026-09-10`, retrieved 2026-10-26)
- Primary completion: 2027-11 (anticipated) (ClinicalTrials.gov record NCT06008197, source copy `cardio:ctgov-nct06008197-2026-09-10`, retrieved 2026-10-26)
- Completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT06008197, source copy `cardio:ctgov-nct06008197-2026-09-10`, retrieved 2026-10-26)
- Countries: United States; Argentina; Australia; Brazil; Bulgaria; Canada; Croatia; Czechia; Germany; Greece; Hungary; India; Italy; Lithuania; Malaysia; Mexico; Peru; Poland; Portugal; Romania; Slovakia; South Korea; Spain; Sri Lanka; Taiwan; United Kingdom (ClinicalTrials.gov record NCT06008197, source copy `cardio:ctgov-nct06008197-2026-09-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06008197-2026-09-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Acronym: REDEFINE-HF
- Condition: Heart Failure
- Condition: Acute Heart Failure
- Intervention (Drug): Finerenone
- Intervention (Drug): Placebo
- Lead sponsor: Colorado Prevention Center
- Lead sponsor class: OTHER
- Collaborator: St. Luke's Hospital, Kansas City, Missouri
- Collaborator class: OTHER
- Collaborator: Bayer
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry intervention name matches this record: Finerenone (`cardio:finerenone`)
- Registry intervention is a member of this class by a sourced record link: Mineralocorticoid receptor antagonists (drug class) (`cardio:mineralocorticoid-receptor-antagonists`)
- Registry lists this organization as the lead sponsor: Colorado Prevention Center (`cardio:org-colorado-prevention-center`)
- Registry lists this organization as a collaborator: St. Luke's Hospital, Kansas City, Missouri (`cardio:org-st-luke-s-hospital-kansas-city-missouri`)
- Registry lists this organization as a collaborator: Bayer (`cardio:bayer`)

## Provenance

Content hash: ab635baca6207cb99890776581ab129da0ea59cf9268298105159cc6e2f71f02
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
